Comparative Pharmacology
Head-to-head clinical analysis: LEVOTHYROXINE versus THYRO TABS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LEVOTHYROXINE versus THYRO TABS.
Levothyroxine vs THYRO-TABS
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Levothyroxine is a synthetic form of thyroxine (T4) that is converted to triiodothyronine (T3) in peripheral tissues. T3 binds to thyroid hormone receptors in the nucleus, regulating gene transcription and increasing metabolic rate, protein synthesis, and oxygen consumption.
THYRO-TABS (levothyroxine) is a synthetic form of thyroxine (T4) that is deiodinated to triiodothyronine (T3) in peripheral tissues, binding to thyroid hormone receptors to regulate gene transcription involved in metabolism, growth, and development.
1.6 mcg/kg orally once daily, adjusted based on TSH levels; typical adult dose 50-200 mcg/day.
Oral, 12.5-25 mcg/day initially, titrated by 12.5-25 mcg every 2-4 weeks based on TSH; typical maintenance dose 50-200 mcg/day.
None Documented
None Documented
Clinical Note
moderateLevothyroxine + Sulfisoxazole
"The metabolism of Sulfisoxazole can be decreased when combined with Levothyroxine."
Clinical Note
moderateLevothyroxine + Erythromycin
"The metabolism of Erythromycin can be decreased when combined with Levothyroxine."
Clinical Note
moderateLevothyroxine + Cyclosporine
"The metabolism of Cyclosporine can be decreased when combined with Levothyroxine."
Clinical Note
moderateLevothyroxine + Fluconazole
7 days (euthyroid); prolonged in hyperthyroidism (3-4 days) and shortened in hypothyroidism (9-10 days); clinical effects persist for weeks after discontinuation due to slow elimination.
Terminal elimination half-life of levothyroxine is approximately 6-7 days in euthyroid individuals; prolonged to 9-10 days in hypothyroidism and shortened to 3-4 days in hyperthyroidism. Half-life may be reduced in patients receiving concurrent enzyme-inducing drugs.
Primarily renal (approximately 50% as unchanged drug and metabolites, mainly glucuronide and sulfate conjugates); minor biliary/fecal excretion (<20%).
Renal (approx. 40-50% as unchanged drug and metabolites, primarily as glucuronide conjugates), fecal (approx. 20-30% via biliary elimination). Minor amounts excreted as unchanged levothyroxine in urine.
Category A/B
Category C
Thyroid Hormone
Thyroid Hormone
"The metabolism of Fluconazole can be decreased when combined with Levothyroxine."